Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors under a spotlight.

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri is putting tumors ...

Using CRISPR-based technologies, the MoDeL team introduces precise genetic modifications in mice, enabling researchers to uncover how mammalian genes maintain health and contribute to disease.

A bacterium living quietly in the intestines of a tiny tree frog has done something cancer researchers spend careers chasing: ...

Cancer cachexia, or the wasting syndrome, is a catastrophic condition that causes dramatic and involuntary loss of muscle mass, fat and weight, alongside extreme fatigue, anorexia and anemia in ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

Biomaterials engineers developed a device with potential to transform cancer immunotherapy! A cost-effective patch that can be placed at the tumor site to recruit immune cells and “train” them to ...